THIOTEPA FOR INJECTION USP
THIOTEPA FOR INJECTION USP
Approved
DIN Number
02526417
Drug Class
Human
Market Date
Feb 15, 2023
Company
HC
Sterimax Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02526417
AIG Number0107649001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01AC01 THIOTEPA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
THIOTEPAActive
Strength: 15 MG / VIAL
Monograph: THIOTEPA